Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

for
Breast Cancer
Location: Boston MA, Wellesley Hills MA, New York NY,
Sponsor: American College of Radiology

Sex: Female

Age: 45 - 70+

Code: NCT05625659

Recruiting

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

for
EGFRI Induced Acneiform Lesions
Location: Boston MA, New York NY, Neptune NJ, Philadelphia PA,
Sponsor: Lutris Pharma Ltd.

Sex: All

Age: 18+

Code: NCT04759664

Phase 2, Recruiting

Head-Cancelled Virtual Reality for Ocular Cranial Nerve Palsies

for
Internuclear Ophthalmoplegia, Palsy, Abducens
Location: Worcester MA, Jacksonville FL
Sponsor: Kevin Houston

Sex: All

Age: 18+

Code: NCT06417216

Recruiting

Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia

for
Osteopenia
Location: Boston MA
Sponsor: Tufts Medical Center

Sex: All

Age: 50+

Code: NCT07473713

Phase 1, Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

for
Muscle Mass and Strength
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 18+

Code: NCT07400419

Recruiting

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

for
Genetic Predisposition, Metabolic Diseases, Type 2 Diabetes
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 65

Code: NCT06003153

Recruiting

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03310879

Phase 2, Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Boston MA, White Plains NY, Westbury NY, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

for
Hypertension, Diabetes, Postpartum, Pregnancy, Anxiety,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT06557005

Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18+

Code: NCT07032662

Phase 2, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase 2, Phase 3, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase 1, Recruiting

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

for
Stenosis of Trachea
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 0+

Code: NCT06761170

Phase 2, Recruiting

Neonatal Platelet Transfusion Threshold Trial

for
Thrombocytopenia, Neonatal, Platelet Transfusion,
Location: Boston MA, Philadelphia PA, Rochester NY, Cleveland OH,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06676904

Recruiting

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

for
Merkel Cell Carcinoma
Location: Boston MA, New York NY, Fairfax VA, Toronto,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT03787602

Phase 1, Phase 2, Recruiting

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

for
Vascular Access Device
Location: Boston MA, Huntsville AL, Loma Linda CA
Sponsor: Teleflex

Sex: All

Age: 0+

Code: NCT06604039

Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Boston MA, The Bronx NY, Cedarhurst NY, New York NY,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase 3, Recruiting

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

for
Castration Resistant Metastatic Prostate Cancer
Location: Boston MA, Baltimore MD, Minneapolis MN, Omaha NE,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18 - 70+

Code: NCT04363164

Phase 2, Recruiting

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

for
Locally Advanced Osteosarcoma, Metastatic Osteosarcoma,
Location: Boston MA, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT05019703

Phase 2, Recruiting